Clinical trial
Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With…
NCT00121602 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00121602 |
|---|---|
| Title | Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease |
| Official title | Randomized, Double-Blind, Equivalence Study of the Efficacy of Darbepoetin Alfa Manufactured by Serum Free Bioreactor Technology and Darbepoetin Alfa Manufactured by Roller-Bottle Technology for the Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Kidney Disease |
| Intervention type | Drug |
| Interventions | Darbepoetin Alfa |
| Enrollment | 446 |
| Start date | Mar 1, 2005 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Jul 21, 2005 |
| Last update posted | Feb 28, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: